<?xml version="1.0" ?>
<document id="26960553">
  <sentence id="26960553.s0" text="The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in L-serine biosynthetic process gene.">
    <entity charOffset="56-68" id="26960553.s0.e0" ontology_id="HP_0000252" text="microcephaly" type="HP"/>
    <entity charOffset="95-101" id="26960553.s0.e1" ontology_id="HP_0001903" text="anemia" type="HP"/>
    <entity charOffset="103-113" id="26960553.s0.e2" ontology_id="HP_0001276" text="hypertonia" type="HP"/>
    <entity charOffset="221-250" id="26960553.s0.e3" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="26960553.s0.e0" e2="26960553.s0.e3" id="26960553.s0.p0" relation="true"/>
    <pair e1="26960553.s0.e1" e2="26960553.s0.e3" id="26960553.s0.p1" relation="true"/>
    <pair e1="26960553.s0.e2" e2="26960553.s0.e3" id="26960553.s0.p2" relation="false"/>
  </sentence>
  <sentence id="26960553.s1" text="The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in L-serine biosynthetic process.">
    <entity charOffset="98-110" id="26960553.s1.e0" ontology_id="HP_0001371" text="contractures" type="HP"/>
    <entity charOffset="182-211" id="26960553.s1.e1" ontology_id="GO_0006564" text="L-serine biosynthetic process" type="GO"/>
    <pair e1="26960553.s1.e0" e2="26960553.s1.e1" id="26960553.s1.p0" relation="false"/>
  </sentence>
  <sentence id="26960553.s2" text="Serine biosynthesis defects result from deficiencies in PGDH, PSAT, or PSP and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe positive regulation of protein phosphorylation to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.">
    <entity charOffset="205-251" id="26960553.s2.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="280-303" id="26960553.s2.e1" ontology_id="HP_0001249" text="intellectual disability" type="HP"/>
  </sentence>
</document>
